Verastem, Inc. Operating Cash Flow
Verastem, Inc. (VSTM) reported Operating Cash Flow of -$96.03 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-06
- Verastem, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$43.91M.
- Verastem, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$52.12M.
- Verastem, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$29.95M.
- Verastem, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$36.22M.
- Verastem, Inc. net cash provided by (used in) operating activities for fiscal 2025 was -$137.51M.
- Verastem, Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$104.77M.
- Verastem, Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$86.46M.
- Verastem, Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$63.67M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$43.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$96.03M 10-Q · filed 2026-08-06 | -$125.98M derived: sum of 3 quarters · filed 2026-08-06 | -$162.19M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$52.12M 10-Q · filed 2026-05-07 | -$82.07M derived: sum of 2 quarters · filed 2026-05-07 | -$118.29M derived: sum of 3 quarters · filed 2026-05-07 | -$150.95M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$29.95M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | -$66.17M derived: sum of 2 quarters · filed 2026-03-04 | -$98.83M derived: sum of 3 quarters · filed 2026-08-06 | -$137.51M 10-K · filed 2026-03-04 |
| 2025-09-30 | -$36.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$68.88M derived: sum of 2 quarters · filed 2026-08-06 | -$107.56M 10-Q · filed 2025-11-04 | -$132.65M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$32.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$71.34M 10-Q · filed 2026-08-06 | -$96.44M derived: sum of 3 quarters · filed 2026-08-06 | -$120.23M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$38.68M 10-Q · filed 2026-05-07 | -$63.77M derived: sum of 2 quarters · filed 2026-05-07 | -$87.57M derived: sum of 3 quarters · filed 2026-05-07 | -$115.14M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$25.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | -$48.89M derived: sum of 2 quarters · filed 2026-03-04 | -$76.46M derived: sum of 3 quarters · filed 2026-03-04 | -$104.77M 10-K · filed 2026-03-04 |
| 2024-09-30 | -$23.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$51.37M derived: sum of 2 quarters · filed 2025-11-04 | -$79.67M 10-Q · filed 2025-11-04 | -$109.35M derived: sum of 4 quarters · filed 2026-03-04 |
| 2024-06-30 | -$27.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$55.88M 10-Q · filed 2025-08-07 | -$85.56M derived: sum of 3 quarters · filed 2026-03-04 | -$102.15M derived: sum of 4 quarters · filed 2026-03-04 |
| 2024-03-31 | -$28.31M 10-Q · filed 2025-05-13 | -$57.99M derived: sum of 2 quarters · filed 2026-03-04 | -$74.58M derived: sum of 3 quarters · filed 2026-03-04 | -$94.48M derived: sum of 4 quarters · filed 2026-03-04 |
| 2023-12-31 | -$29.68M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | -$46.27M derived: sum of 2 quarters · filed 2026-03-04 | -$66.17M derived: sum of 3 quarters · filed 2026-03-04 | -$86.46M 10-K · filed 2026-03-04 |
| 2023-09-30 | -$16.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | -$36.49M derived: sum of 2 quarters · filed 2024-11-06 | -$56.78M 10-Q · filed 2024-11-06 | -$73.39M derived: sum of 4 quarters · filed 2025-03-20 |
| 2023-06-30 | -$19.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$40.19M 10-Q · filed 2024-08-08 | -$56.81M derived: sum of 3 quarters · filed 2025-03-20 | -$71.89M derived: sum of 4 quarters · filed 2025-03-20 |
| 2023-03-31 | -$20.29M 10-Q · filed 2024-05-09 | -$36.90M derived: sum of 2 quarters · filed 2025-03-20 | -$51.98M derived: sum of 3 quarters · filed 2025-03-20 | -$64.68M derived: sum of 4 quarters · filed 2025-03-20 |
| 2022-12-31 | -$16.62M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | -$31.70M derived: sum of 2 quarters · filed 2025-03-20 | -$44.39M derived: sum of 3 quarters · filed 2025-03-20 | -$63.67M 10-K · filed 2025-03-20 |
| 2022-09-30 | -$15.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$27.78M derived: sum of 2 quarters · filed 2023-11-08 | -$47.06M 10-Q · filed 2023-11-08 | -$56.99M derived: sum of 4 quarters · filed 2024-03-14 |
| 2022-06-30 | -$12.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$31.98M 10-Q · filed 2023-08-08 | -$41.91M derived: sum of 3 quarters · filed 2024-03-14 | -$52.73M derived: sum of 4 quarters · filed 2024-03-14 |
| 2022-03-31 | -$19.28M 10-Q · filed 2023-05-09 | -$29.21M derived: sum of 2 quarters · filed 2024-03-14 | -$40.04M derived: sum of 3 quarters · filed 2024-03-14 | -$53.47M derived: sum of 4 quarters · filed 2024-03-14 |
| 2021-12-31 | -$9.93M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | -$20.76M derived: sum of 2 quarters · filed 2024-03-14 | -$34.18M derived: sum of 3 quarters · filed 2024-03-14 | -$53.50M 10-K · filed 2024-03-14 |
| 2021-09-30 | -$10.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$24.25M derived: sum of 2 quarters · filed 2022-11-03 | -$43.57M 10-Q · filed 2022-11-03 | -$65.27M derived: sum of 4 quarters · filed 2023-03-14 |
| 2021-06-30 | -$13.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$32.74M 10-Q · filed 2022-08-08 | -$54.45M derived: sum of 3 quarters · filed 2023-03-14 | -$9.70M derived: sum of 4 quarters · filed 2023-03-14 |
| 2021-03-31 | -$19.32M 10-Q · filed 2022-05-09 | -$41.02M derived: sum of 2 quarters · filed 2023-03-14 | $3.73M derived: sum of 3 quarters · filed 2023-03-14 | -$18.82M derived: sum of 4 quarters · filed 2023-03-14 |
| 2020-12-31 | -$21.70M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $23.04M derived: sum of 2 quarters · filed 2023-03-14 | $497.00K derived: sum of 3 quarters · filed 2023-03-14 | -$33.51M 10-K · filed 2023-03-14 |
| 2020-09-30 | $44.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $22.20M derived: sum of 2 quarters · filed 2021-11-04 | -$11.80M 10-Q · filed 2021-11-04 | -$49.02M derived: sum of 4 quarters · filed 2022-03-28 |
| 2020-06-30 | -$22.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-02 | -$56.55M 10-Q · filed 2021-08-02 | -$93.77M derived: sum of 3 quarters · filed 2022-03-28 | -$121.62M derived: sum of 4 quarters · filed 2022-03-28 |
| 2020-03-31 | -$34.00M 10-Q · filed 2021-05-11 | -$71.22M derived: sum of 2 quarters · filed 2022-03-28 | -$99.07M derived: sum of 3 quarters · filed 2022-03-28 | -$133.74M derived: sum of 4 quarters · filed 2022-03-28 |
| 2019-12-31 | -$37.22M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | -$65.07M derived: sum of 2 quarters · filed 2022-03-28 | -$99.74M derived: sum of 3 quarters · filed 2022-03-28 | -$138.52M 10-K · filed 2022-03-28 |
| 2019-09-30 | -$27.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$62.52M derived: sum of 2 quarters · filed 2020-11-09 | -$101.30M 10-Q · filed 2020-11-09 | -$120.48M derived: sum of 4 quarters · filed 2021-03-18 |
| 2019-06-30 | -$34.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$73.45M 10-Q · filed 2020-08-10 | -$92.64M derived: sum of 3 quarters · filed 2021-03-18 | -$115.20M derived: sum of 4 quarters · filed 2021-03-18 |
| 2019-03-31 | -$38.78M 10-Q · filed 2020-05-07 | -$57.97M derived: sum of 2 quarters · filed 2021-03-18 | -$80.53M derived: sum of 3 quarters · filed 2021-03-18 | -$90.84M derived: sum of 4 quarters · filed 2021-03-18 |
| 2018-12-31 | -$19.19M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | -$41.75M derived: sum of 2 quarters · filed 2021-03-18 | -$52.06M derived: sum of 3 quarters · filed 2021-03-18 | -$74.52M 10-K · filed 2021-03-18 |
| 2018-09-30 | -$22.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | -$32.87M derived: sum of 2 quarters · filed 2019-10-30 | -$55.33M 10-Q · filed 2019-10-30 | -$75.65M derived: sum of 4 quarters · filed 2020-03-11 |
| 2018-06-30 | -$10.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | -$32.77M 10-Q · filed 2019-08-01 | -$53.09M derived: sum of 3 quarters · filed 2020-03-11 | -$64.94M derived: sum of 4 quarters · filed 2020-03-11 |
| 2018-03-31 | -$22.45M 10-Q · filed 2019-05-09 | -$42.78M derived: sum of 2 quarters · filed 2020-03-11 | -$54.63M derived: sum of 3 quarters · filed 2020-03-11 | -$69.11M derived: sum of 4 quarters · filed 2020-03-11 |
| 2017-12-31 | -$20.33M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | -$32.18M derived: sum of 2 quarters · filed 2020-03-11 | -$46.66M derived: sum of 3 quarters · filed 2020-03-11 | -$57.31M 10-K · filed 2020-03-11 |
| 2017-09-30 | -$11.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | -$26.33M derived: sum of 2 quarters · filed 2018-11-07 | -$36.98M 10-Q · filed 2018-11-07 | -$42.94M derived: sum of 4 quarters · filed 2019-03-12 |
| 2017-06-30 | -$14.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | -$25.13M 10-Q · filed 2018-08-08 | -$31.09M derived: sum of 3 quarters · filed 2019-03-12 | -$37.10M derived: sum of 4 quarters · filed 2019-03-12 |
| 2017-03-31 | -$10.65M 10-Q · filed 2018-05-03 | -$16.60M derived: sum of 2 quarters · filed 2019-03-12 | -$22.62M derived: sum of 3 quarters · filed 2019-03-12 | |
| 2016-12-31 | -$5.95M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | -$11.97M derived: sum of 2 quarters · filed 2019-03-12 | -$29.48M 10-K · filed 2019-03-12 | |
| 2016-09-30 | -$6.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | -$23.53M 10-Q · filed 2017-11-07 | ||
| 2016-06-30 | -$17.51M 10-Q · filed 2017-08-08 | |||
| 2015-12-31 | -$45.56M 10-K · filed 2018-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 |